z-logo
open-access-imgOpen Access
Antibiotic resistance in patients with chronic ear discharge awaiting surgery in Nepal
Author(s) -
Rajiv Ranjan Karn,
Rabin Acharya,
Amit Rajbanshi,
Sanjay Kumar Singh,
Sanjeev Kumar Thakur,
Shreni Shah,
A. K. Singh,
Rajeev Shah,
SU Kafle,
Maya Bhattachan,
Arminé Abrahamyan,
Hemant Deepak Shewade,
Rony Zachariah
Publication year - 2021
Publication title -
public health action
Language(s) - English
Resource type - Journals
ISSN - 2220-8372
DOI - 10.5588/pha.21.0029
Subject(s) - medicine , amikacin , antibiotics , vancomycin , chronic suppurative otitis media , antibiotic resistance , surgery , staphylococcus aureus , microbiology and biotechnology , bacteria , genetics , biology
SETTING: Biratnagar Eye Hospital, Biratnagar, Nepal, which offers ear surgery for chronic suppurative otitis media (CSOM). OBJECTIVE: In patients with CSOM awaiting surgery, to determine the 1) sociodemographic characteristics 2) bacterial isolates and their antibiotic resistance patterns and 3) characteristics of those refused surgery, including antibiotic resistance. DESIGN: A cohort study using hospital data, January 2018–January 2020. RESULTS: Of 117 patients with CSOM and awaiting surgery, 64% were in the 18–35 years age group, and 79% were cross-border from India. Of 118 bacterial isolates, 80% had Pseudomonas aeruginosa and 16% had Staphylococcus aureus . All isolates showed multidrug resistance to nine of the 12 antibiotics tested. The lowest antibiotic resistance in P. aeruginosa was for vancomycin (29%) and moxifloxacin (36%), and for S. aureus , this was vancomycin (9%) and amikacin (17%). Fourteen (12%) patients underwent surgery: myringoplasty ( n = 7, 50%), cortical mastoidectomy with tympanostomy ( n = 4, 29%) and modified radical mastoidectomy ( n = 3, 21%). Those infected with P. aeruginosa and with resistance to over six antibiotics were significantly more likely to be refused for surgery. CONCLUSION: Patients awaiting ear surgery were predominantly infected with multidrug-resistant P. aeruginosa and were consequently refused surgery. This study can help inform efforts for improving surgical uptake and introducing cross-border antimicrobial resistance surveillance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom